Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer

被引:220
作者
Chin, Y. Rebecca [1 ]
Toker, Alex [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Akt; PI; 3-K; Breast cancer; Cell motility; Metastasis; Signal transduction; ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-B; MIDDLE-T-ANTIGEN; EPITHELIAL-MESENCHYMAL TRANSITION; PLECKSTRIN-HOMOLOGY-DOMAIN; VEGF-MEDIATED ANGIOGENESIS; BREAST-CANCER; PHOSPHATIDYLINOSITOL; 3-KINASE; PATHOLOGICAL ANGIOGENESIS; MAMMARY TUMORIGENESIS;
D O I
10.1016/j.cellsig.2008.11.015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The serine/threonine protein kinase Akt is a major signal transducer of the phosphoinositide 3-kinase (PI 3-K) pathway in all cells and tissues and plays a pivotal role in the maintenance of cellular processes including cell growth, proliferation, survival and metabolism. The frequent aberrant activation of the PI 3-K/Akt pathway in human cancer has made it an attractive therapeutic target. Numerous studies have provided a comprehensive understanding of the specific functions of Akt signaling in cancer cells as well as the surrounding tumor microenvironment and this has informed and enabled the development of therapeutic drugs to target both PI recentstudies have provided evidence for distinct functions of the three mammalian Akt 3-K and Akt. However, isoforms, particularly with respect to the regulation of cell motility and metastasis of breast cancer. Here we discuss the mechanisms by which Akt signaling contributes to invasive migration and tumor metastasis, and highlight recent advances in our understanding of the contribution of the Akt pathway in the tumor-associated stroma. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 75 条
[1]   Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis [J].
Ackah, E ;
Yu, J ;
Zoellner, S ;
Iwakiri, Y ;
Skurk, C ;
Shibata, R ;
Ouchi, N ;
Easton, RM ;
Galasso, G ;
Birnbaum, MJ ;
Walsh, K ;
Sessa, WC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2119-2127
[2]   Perturbations of the AKT signaling pathway in human cancer [J].
Altomare, DA ;
Testa, JR .
ONCOGENE, 2005, 24 (50) :7455-7464
[3]  
Aoki T, 2002, ONCOL REP, V9, P761
[4]  
Arboleda MJ, 2003, CANCER RES, V63, P196
[5]  
Azenshtein E, 2002, CANCER RES, V62, P1093
[6]   Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors [J].
Barnett, SF ;
Defeo-Jones, D ;
Fu, S ;
Hancock, PJ ;
Haskell, KM ;
Jones, RE ;
Kahana, JA ;
Kral, AM ;
Leander, K ;
Lee, LL ;
Malinowski, J ;
McAvoy, EM ;
Nahas, DD ;
Robinson, RG ;
Huber, HE .
BIOCHEMICAL JOURNAL, 2005, 385 :399-408
[7]   Activation of AKT kinases in cancer: Implications for therapeutic targeting [J].
Bellacosa, A ;
Kumar, CC ;
Di Cristofano, A ;
Testa, JR .
ADVANCES IN CANCER RESEARCH, VOL 94, 2005, 94 :29-+
[8]   A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION [J].
BELLACOSA, A ;
TESTA, JR ;
STAAL, SP ;
TSICHLIS, PN .
SCIENCE, 1991, 254 (5029) :274-277
[9]   CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment [J].
Burger, JA ;
Kipps, TJ .
BLOOD, 2006, 107 (05) :1761-1767
[10]   A transforming mutation in the pleckstrin homology domain of AKT1 in cancer [J].
Carpten, John D. ;
Faber, Andrew L. ;
Horn, Candice ;
Donoho, Gregory P. ;
Briggs, Stephen L. ;
Robbins, Christiane M. ;
Hostetter, Galen ;
Boguslawski, Sophie ;
Moses, Tracy Y. ;
Savage, Stephanie ;
Uhlik, Mark ;
Lin, Aimin ;
Du, Jian ;
Qian, Yue-Wei ;
Zeckner, Douglas J. ;
Tucker-Kellogg, Greg ;
Touchman, Jeffrey ;
Patel, Ketan ;
Mousses, Spyro ;
Bittner, Michael ;
Schevitz, Richard ;
Lai, Mei-Huei T. ;
Blanchard, Kerry L. ;
Thomas, James E. .
NATURE, 2007, 448 (7152) :439-U1